DiaMedica Therapeutics (DMAC) Total Current Liabilities (2017 - 2026)

DiaMedica Therapeutics' (DMAC) quarterly Total Current Liabilities came in at $5.7 million in Q1 2026, up 23.22% year-on-year from $4.7 million in Q1 2025, and up 12.0% quarter-over-quarter from $5.1 million in Q4 2025.

DiaMedica Therapeutics (DMAC) Total Current Liabilities (2017 - 2026) Analysis & Trends

DiaMedica Therapeutics' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 23.22% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 23.22% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, down 4.79% from the prior year.
  • Total Current Liabilities advanced to $5.7 million in Q1 2026 per DMAC's latest filing, from $5.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $5.7 million in Q1 2026 and bottomed at $1.4 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $2.8 million (2023), against an average of $3.3 million.
  • Biggest YoY gain for Total Current Liabilities was 98.02% in 2024; the steepest drop was 7.0% in 2024.
  • Year by year, Total Current Liabilities stood at $2.2 million in 2022, then increased by 28.51% to $2.8 million in 2023, then jumped by 93.47% to $5.4 million in 2024, then fell by 4.79% to $5.1 million in 2025, then gained by 12.0% to $5.7 million in 2026.
  • Per Business Quant, the three latest DMAC Total Current Liabilities figures stand at $5.7 million (Q1 2026), $5.1 million (Q4 2025), and $5.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 DiaMedica Therapeutics 366.87 Mn 366.87 Mn - 5.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.75 Mn
Dec 31, 2025 5.13 Mn
Sep 30, 2025 5.27 Mn
Jun 30, 2025 4.12 Mn
Mar 31, 2025 4.67 Mn
Dec 31, 2024 5.39 Mn
Sep 30, 2024 4.30 Mn
Jun 30, 2024 3.09 Mn
Mar 31, 2024 2.62 Mn
Dec 31, 2023 2.79 Mn
Sep 30, 2023 2.17 Mn
Jun 30, 2023 1.95 Mn
Mar 31, 2023 2.81 Mn
Dec 31, 2022 2.17 Mn
Sep 30, 2022 1.54 Mn
Jun 30, 2022 1.54 Mn
Mar 31, 2022 1.43 Mn
Dec 31, 2021 1.52 Mn
Sep 30, 2021 1.62 Mn
Jun 30, 2021 1.44 Mn